<DOC>
	<DOCNO>NCT01834807</DOCNO>
	<brief_summary>This retrospective , observational , multi-center study evaluate use biological agent ( e.g . RoActemra/Actemra [ tocilizumab ] ) monotherapy patient rheumatoid arthritis . Data medical record file collect patient currently treat biologic monotherapy .</brief_summary>
	<brief_title>A Retrospective Observational Study Use Biologics Monotherapy Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Diagnosis rheumatoid arthritis Currently receive biologic agent monotherapy ( corticosteroid and/or nonsteroidal antiinflammatory drug permit ) Concomitant treatment diseasemodifying antirheumatic drug ( DMARDs ) treatment rheumatoid arthritis Patients start current monotherapy 01/01/2009</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>